JOURNAL
Current Issue
Journal Archive
.............................................................
November 2021 -
Volume 19, Issue 11


View this issue in pdf format

........................................................
From the Editor

........................................................

 

Prevalence and Associated Factors of Diabetic ketoacidosis among Patients Living with Type 1 Diabetes in Makkah Al-Mukarramah City
[Abstract]
[pdf]

Raghad Alhajaji, Khalid Almasodi, Afaf Alhajaji, Ahmad Alturkstani, Mayada Samkari
DOI: 10.5742/MEWFM.2021.94154

Gender differences of the clinical aspects and complication risks of diabetes mellitus among outpatient clinic visits, Jeddah, Saudi Arabia
[Abstract]
[pdf]

Fathi El-Gamal, Abdulrahim Aljudaibi, Ahmed Alzahrani,
Layla Alharthy, Turki Huwait
DOI: 10.5742/MEWFM.2021.94155

Prevention of developmental delays among children at public healthcare facilities of Pakistan: protocol for a cluster Randomized Controlled Trial
[Abstract]
[pdf]

Nida Khan, Muhammad Amir Khan, Muhammad Ahmar Khan, Amna Ejaz, Azza Warraitch, Haroon Jehangir Khan
DOI: 10.5742/MEWFM.2021.94156

A retrospective study of thyroid hormone in Pediatrics: relationships with growth hormone correlation with effects of diabetes in Riyadh, Saudi Arabia
[Abstract]
[pdf]

Faisal Mujeb Alshareef, Abdullah Hamad Alfaris, Nouryah Abdulaziz Alhafez, Alanoud Saleh Albuloshi, Abdulaziz Mshaal Aljuhni, Khalid Abdulrahman Almahmoud, Majed Abdulaziz Almajdui,
Khalid Ebrahim Alswayed, Saad Ibrahim Alghuraybi, Saleh Abdulmoneim Alomary, Abdullah Ahmad Alkhudher, Faisal Turki G Alharbi, Mohammed Ahmed Almuhanna, Musaad Abdulaziz Alrashod,
Khalid Ahmed Aljasser
DOI: 10.5742/MEWFM.2021.94157

Regional Covid

Impact of COVID-19 on patients receiving chemotherapy for gynecological cancer
[Abstract]
[pdf]

Mahmoud N. Andijani, Ahmad O. Alibrahim, Sheren F. Tmraz, Lamees F. ALshenqity, Abdulaziz S. Alaama, Bayan A. Zaatari, Nisreen M. Anfinan, Khalid H. Sait
DOI: 10.5742/MEWFM.2021.94158

Immune system response to the Covid 19 virus and 3rd boosters
[Abstract]
[pdf]

Mark Spigelman
DOI: 10.5742/MEWFM.2021.94159

Impact of Covid-19 on asthmatic patients in Western region in Saudi Arabia
[Abstract]
[pdf]

Abdulrhman Nasser Zaher Alghamdi, Amal Mohammed Albaqami, Areej Mohammed Abdullah,
Doha Abdulrahmman Alsukhayri, Hamad Albulrahman Alawi, Ameera Saeed Baabbad
DOI: 10.5742/MEWFM.2021.94161

Population and Community Studies

Knowledge, Attitude and Awareness towards Corneal Donation in Aseer Region, Saudi Arabia
[Abstract]
[pdf]

Abdulrahman Mohammed Al-Amri, Faisal Misfer Alqahtani, Hassan Abdullah Alqahtani, Mansour Salem Alqahtani, Mohammed Moshabbab Alqahtani, Musaad Abdulrhman Al Shibli,
Riyad Ali Almastour, Abdulrahman Mohammed Al-Amri
DOI: 10.5742/MEWFM.2021.94162

Comparison of Body Image Perception and Depression in Polycystic Ovarian Syndrome (PCOS) and Non-PCOS Women
[Abstract]
[pdf]

Sassi Kanwal, Syeda Sadia Fatima, Fatima Abid, Aliya Jafri, Fatima Hasan Kazmi, Nargis Fatima
DOI: 10.5742/MEWFM.2021.94163

Factors Associated with Not Continuing Initiated Breastfeeding among Saudi Females in Abha
[Abstract]
[pdf]

Yasmin Taha Mandoura, Majed Alsaleh, Safar Abadi Al-Saleem
DOI: 10.5742/MEWFM.2021.94164

Education and Training

Does test anxiety and gender have an impact on OSCE Performance among medical students?
[Abstract]
[pdf]

Farzana Rizwan Arain
DOI: 10.5742/MEWFM.2021.94165

Reviews

Clinical Efficacy and Cholesterol-Lowering Effects of Inclisiran
[Abstract]
[pdf]

Muhammad Danial bin Daud
DOI: 10.5742/MEWFM.2021.94166

Malignant Melanoma
[Abstract]
[pdf]

Mazin Abdalla
DOI: 10.5742/MEWFM.2021.94167

Non-surgical options to treat androgenic alopecia
[Abstract]
[pdf]

Mazin Abdalla
DOI: 10.5742/MEWFM.2021.94168
........................................................................

Middle East Quality Improvement Program
(MEQUIP QI&CPD)


Chief Editor -
Abdulrazak Abyad MD, MPH, MBA, AGSF, AFCHSE

.........................................................

Publisher -
Lesley Pocock
medi+WORLD International
AUSTRALIA
Email
: lesleypocock@mediworld.com.au
.........................................................

Editorial Enquiries -
abyad@cyberia.net.lb
.........................................................

Advertising Enquiries -
lesleypocock@mediworld.com.au
.........................................................

While all efforts have been made to ensure the accuracy of the information in this journal, opinions expressed are those of the authors and do not necessarily reflect the views of The Publishers, Editor or the Editorial Board. The publishers, Editor and Editorial Board cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; or the views and opinions expressed. Publication of any advertisements does not constitute any endorsement by the Publishers and Editors of the product advertised.

The contents of this journal are copyright. Apart from any fair dealing for purposes of private study, research, criticism or review, as permitted under the Australian Copyright Act, no part of this program may be reproduced without the permission of the publisher.

 

 

 

 

 

 

 


 


 

 


 

 

 

   
November 2021 - Volume 19, Issue 11

Impact of COVID-19 on patients receiving chemotherapy for gynecological cancer

Abstract


Background: Cancer patients’ increased susceptibility to serious COVID-19 complications can be attributed to the immunosuppressed state caused by the disease and anticancer treatments such as chemotherapy or surgery.

Objectives: To assess the effect of COVID-19 pandemic on gynecological cancer patients
receiving chemotherapy.

Methods:
A cross-sectional study was conducted on patients receiving chemotherapy for gynecological cancer between (March 2020 to February 2021) at King Abdulaziz University Hospital (KAUH) in Jeddah, Saudi Arabia. Clinical data collected from medical records included patients’ ages, medical history data, cycles of chemotherapy, COVID-19 infection, complications and death.

Results: Total of 84 patients were identified. The mean age of studied patients was 53.81 ± 13.76 years, and the most common chronic diseases were HTN (35.7%) and DM (23.8%). The majority of diagnoses were ovarian cancer (41.7%) followed by uterine cancer (33.3%). Of studied patients, 17.9%, 19.1%, 27.4 and 33.3% had I, II , III and IV cancer stages respectively. The mean number of cycles of chemotherapy was 7.14 ± 5.55. 52.4% had first line chemotherapy. 57 percent of patients had delays due to various causes, including COVID-19
infection, and 9 percent of patients had COVID-19 while on therapy. 15 percent of the delays were caused by patients who were affected by Covid-19 while receiving chemotherapy and 2% of the patients died as a result of COVID-19 . Patients with recurrent disease had a significantly higher percentage of patients detected with COVID-19, and all cases detected with COVID-19 died with respiratory failure. Patients who had their chemotherapy delayed had a significantly higher mean number of cycles.

Conclusion: Improved communication and management programs are required to keep cancer patients and their healthcare providers connected, as well as to allow cancer patients to survive a pandemic.

Key words: Impact, COVID-19, patients, chemotherapy, Jeddah, Saudi Arabia.







 


 

.................................................................................................................